Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer. [electronic resource]
- Apoptosis : an international journal on programmed cell death 11 2016
- 1265-1278 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-675X
10.1007/s10495-016-1284-8 doi
Animals Antineoplastic Agents--administration & dosage Apoptosis--drug effects Cell Cycle--drug effects Cell Line, Tumor Cisplatin--administration & dosage Drug Resistance, Neoplasm--drug effects Drugs, Chinese Herbal--administration & dosage Flavanones--administration & dosage Glutathione Transferase--genetics Head and Neck Neoplasms--drug therapy Humans Male Mice Mice, Inbred C57BL Mice, Nude NF-E2-Related Factor 2--genetics Reactive Oxygen Species--metabolism Scutellaria baicalensis--chemistry Xenograft Model Antitumor Assays